Skip to main content

CORRECTION article

Front. Pharmacol., 12 October 2022
Sec. Ethnopharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1034753

Corrigendum: Liquid chromatograph-mass spectrometry-based non-targeted metabolomics discovery of potential endogenous biomarkers associated with prostatitis rats to reveal the effects of magnoflorine

This article is a correction to:

  1. Liquid Chromatograph-Mass Spectrometry-Based Non-targeted Metabolomics Discovery of Potential Endogenous Biomarkers Associated With Prostatitis Rats to Reveal the Effects of Magnoflorine

    1. Read original article
Yin Yuan Yin Yuan1*Fei-Xue DongFei-Xue Dong2Xu LiuXu Liu1Hong-Bin Xiao Hong-Bin Xiao3*Zhong-Guang Zhou Zhong-Guang Zhou4*
  • 1Department of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin, China
  • 2First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China
  • 3Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China
  • 4Research Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China

A Corrigendum on
Liquid chromatograph-mass spectrometry-based non-targeted metabolomics discovery of potential endogenous biomarkers associated with prostatitis rats to reveal the effects of magnoflorine

by Yuan Y, Dong F-X, Liu X, Xiao H-B and Zhou Z-G (2021). Front. Pharmacol. 12:741378. doi: 10.3389/fphar.2021.741378

In the published article, there was an error in Supplementary Tables S1, S2, S5, S6. We have submitted the wrong version of the supplementary material. The correct material appears in Supplementary Material.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2022.1034753/full#supplementary-material

Keywords: metabolomics, UPLC-MS, metabolites, pathways, metabolite biomarkers

Citation: Yuan Y, Dong F-X, Liu X, Xiao H-B and Zhou Z-G (2022) Corrigendum: Liquid chromatograph-mass spectrometry-based non-targeted metabolomics discovery of potential endogenous biomarkers associated with prostatitis rats to reveal the effects of magnoflorine. Front. Pharmacol. 13:1034753. doi: 10.3389/fphar.2022.1034753

Received: 02 September 2022; Accepted: 21 September 2022;
Published: 12 October 2022.

Edited and reviewed by:

Ke-Wu Zeng, Health Science Centre, Peking University, China

Copyright © 2022 Yuan, Dong, Liu, Xiao and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yin Yuan, yuanyin309@163.com; Hong-Bin Xiao, hrbxiaohongbin@126.com; Zhong-Guang Zhou, zzg5709@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.